Search | VHL TCIM Americas

Drekonja, Dimitri M; Beekmann, Susan E; Elliott, Sean; Mukundan, Deepa; Polenakovik, Hari; Rosenthal, Marnie E; Tamma, Pranita D; Polgreen, Philip M; Weissman, Scott J.

Infect Control Hosp Epidemiol ; 35(4): 437-9, 2014 Apr.

Article in English | MEDLINE | ID: mdl-24602953

ABSTRACT

Carbapenem-resistant Enterobacteriaceae (CRE) infections are increasing and are associated with considerable morbidity and mortality. Members of the Emerging Infections Network treating CRE encountered difficulties in obtaining laboratory results and struggled with limited treatment options. In addition, many treated patients experienced an alarming degree of drug toxicity from CRE therapies.

Subject(s)

Carbapenems/therapeutic use , Drug Resistance, Bacterial , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae/drug effects , Adult , Carbapenems/pharmacology , Female , Humans , Male , Microbial Sensitivity Tests , Surveys and Questionnaires

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL